Facts and Myths Regarding COVID-19 in Athletes

Sayed Yasser Ahmed Nisar (1)
(1) Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India, India

Abstract

After the rise of the Coronavirus infection from the country of China in the year-end of 2019, brought about by the Novel Coronavirus, a total of approximately 45 million cases all around the world with deaths of more than 1.17 million individuals and 29.8 million recoveries. The SARS-COV2, also known as the coronavirus, usually presents as an asymptomatic carrier state with respiratory illness and pneumonia-like symptoms. Grown-ups speak to the populace with the largest rate of infection; in any case, youngsters, kids, and old patients can likewise be affected by the virus. The most widely seen abnormality on chest x-ray amongst individuals with lung infection was ground-glass opacity, with B/L findings. Serious cases are bound to be found in patients with other illnesses contrasted with other non-serious cases. In reality, age and illness seriousness might be corresponded with the results of the coronavirus disease. Until this point, viable treatment is missing; notwithstanding, clinical preliminaries researching the viability of a few drugs, including remdesivir and chloroquine, are in progress. Right now, viable contamination control poses the best method to forestall the outbreak of the virus.

Full text article

Generated from XML file

Authors

Sayed Yasser Ahmed Nisar
yasserahmed1000@gmail.com (Primary Contact)
Sayed Yasser Ahmed Nisar. (2020). Facts and Myths Regarding COVID-19 in Athletes. International Journal of Research in Pharmaceutical Sciences, 11((SPL 1), 1677–1681. Retrieved from https://ijrps.com/home/article/view/2034

Article Details

No Related Submission Found